Prognostic value of [18F]FDG-PET/CT in multiple myeloma patients before and after allogeneic hematopoietic cell transplantation-Reference-Cited by-同舟云学术

Prognostic value of [18F]FDG-PET/CT in multiple myeloma patients before and after allogeneic hematopoietic cell transplantation

Published:2018-04-02 Issue:10 Volume:45 Page:1694-1704
ISSN:1619-7070
Container-title:European Journal of Nuclear Medicine and Molecular Imaging
language:en
Short-container-title:Eur J Nucl Med Mol Imaging

Author:

Stolzenburg Antje,Lückerath Katharina,Samnick Samuel,Speer Martin,Kneer Katharina,Schmid Jan-Stefan,Grigoleit Götz Ulrich,Hofmann Susanne,Beer Ambros J.,Bunjes Donald,Knop Stefan,Buck Andreas K.,Einsele Hermann,Lapa Constantin^ORCID

Funder

Wilhelm Sander-Stiftung

Publisher

Springer Science and Business Media LLC

Subject

Radiology Nuclear Medicine and imaging,General Medicine,Radiology Nuclear Medicine and imaging,General Medicine

Link

http://link.springer.com/article/10.1007/s00259-018-3997-0/fulltext.html

Reference32 articles.

1. Kumar S, Paiva B, Anderson KC, Durie B, Landgren O, Moreau P, et al. International myeloma working group consensus criteria for response and minimal residual disease assessment in multiple myeloma. Lancet Oncol. 2016;17(8):e328–e46.

2. Bensinger WI, Maloney D, Storb R. Allogeneic hematopoietic cell transplantation for multiple myeloma. Sem Hematol. 2001;38(3):243–9.

3. Sobh M, Michallet M, Gahrton G, Iacobelli S, van Biezen A, Schonland S, et al. Allogeneic hematopoietic cell transplantation for multiple myeloma in Europe: trends and outcomes over 25 years. A study by the EBMT chronic malignancies working party. Leukemia. 2016; https://doi.org/10.1038/leu.2016.101 .

4. Hagen PA, Rodriguez TE, Smith S, Tsai S, Al-Mansour Z, Adams W, et al. Timing of allogeneic hematopoietic cell transplantation for high risk multiple myeloma. Biol Blood Marrow Transplant. 2017;23(3):S266.

5. Oostvogels R, Uniken Venema SM, de Witte M, Raymakers R, Kuball J, Kroger N, et al. In search of the optimal platform for post-allogeneic SCT immunotherapy in relapsed multiple myeloma: a systematic review. Bone Marrow Transplant. 2017;52(9):1233–40. https://doi.org/10.1038/bmt.2017.141 .

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Coefficient of variation and texture analysis of 18F-FDG PET/CT images for the prediction of outcome in patients with multiple myeloma;Annals of Hematology;2024-07-24

2. Positron Emission Tomography/Computed Tomography Transformation of Oncology;PET Clinics;2024-04

3. Recent advances in imaging and artificial intelligence (AI) for quantitative assessment of multiple myeloma;American Journal of Nuclear Medicine and Molecular Imaging;2024

4. Quantitation of Oncologic Image Features for Radiomic Analyses in PET;Methods in Molecular Biology;2023-11-26

5. New Developments in Myeloma Treatment and Response Assessment;Journal of Nuclear Medicine;2023-08-17